HLA antibody specification and target epitope identification. (A) Frequency of patient antibody specificities and degree of HLA sensitization as defined by CRFs of >80% vs <85%. (B) Percentage of patients with antibodies directed against specific and groups of HLA antigens and according to the degree of HLA sensitization. (C) Amino acid composition of eplet epitopes more frequently found in highly sensitized patients.